Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Faculté Rockefeller, Centre de Recherche en Cancérologie de Lyon, 8 avenue Rockefeller, 69008, Lyon, France.
Purinergic Signal. 2018 Dec;14(4):321-329. doi: 10.1007/s11302-018-9627-2. Epub 2018 Oct 25.
Purine metabolism is depending on a large amount of enzymes to ensure cellular homeostasis. Among these enzymes, we have been interested in the 5'-nucleotidase cN-II and its role in cancer biology and in response of cancer cells to treatments. This protein has been cited and studied in a large number of papers published during the last decade for its involvement in non-cancerous pathologies such as hereditary spastic paraplegia, schizophrenia, and blood pressure regulation. Here, we review these articles in order to give an overview of the recently discovered clinical relevance of cN-II.
嘌呤代谢依赖于大量的酶来确保细胞内环境的稳定。在这些酶中,我们对 5'-核苷酸酶 cN-II 及其在癌症生物学和癌细胞对治疗的反应中的作用很感兴趣。由于该蛋白与非癌性疾病(如遗传性痉挛性截瘫、精神分裂症和血压调节)有关,在过去十年发表的大量论文中都引用和研究过它。在这里,我们回顾这些文章,以便概述最近发现的 cN-II 的临床相关性。